Advertisement

Plastic surgical management of skin cancer patients during the COVID-19 pandemic

Published:September 19, 2020DOI:https://doi.org/10.1016/j.bjps.2020.08.143
      The first confirmed cases of SARS-CoV-2 cornovirus disease (COVID-19) in the UK were on 29th January 2020. On 23rd March, a UK-wide “stay at home” lockdown period commenced, restricting freedom of movement in an effort to mitigate viral spread and protect NHS resources. At the time of writing, the UK has had over 300,000 confirmed cases of COVID-19 with a death toll of over 43,000 people.

      Coronavirus Resource Centre. Johns Hopkins University. https://coronavirus.jhu.edu. [Accessibility verified June 26, 2020].

      Many NHS hospitals across the UK are in various stages of lockdown as resources are redirected to the frontline.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Coronavirus Resource Centre. Johns Hopkins University. https://coronavirus.jhu.edu. [Accessibility verified June 26, 2020].

      2. British Association of Plastic Reconstructive and Aesthetic Surgeons. COVID-19 advice for members. http://www.bapras.org.uk/professionals/About/member-resources/covid-19-advice-for-members. [Accessibility verified July 1, 2020].

      3. British Association of Dermatologists & British Society for Dermatological Surgery COVID-19 – Skin cancer surgery guideline. Clinical guidance for the management of skin cancer patients during the coronavirus pandemic. https://www.bad.org.uk/healthcare-professionals/covid-19. [Accessibility verified June 1, 2020].